Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 Trial. (2023)
Attributed to:
Blood borne viruses
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/cid/ciad346
PubMed Identifier: 37280040
Publication URI: http://europepmc.org/abstract/MED/37280040
Type: Journal Article/Review
Volume: 77
Parent Publication: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Issue: 9
ISSN: 1058-4838